| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |